ANVISA, Brazil’s Health Surveillance Agency, has approved sale of Kemin’s ZeaONE.
ANVISA, Brazil’s Health Surveillance Agency, has approved for sale ZeaONE Zeaxanthin from Kemin Health LC (Des Moines,IA). The news allows Kemin to begin immediate marketing in Brazil of ZeaONE, a zeaxanthin ingredient sourced from a parented line of marigolds.
Like lutein, zeaxanthin has shown promise for health conditions like skin health and eye health in multiple scientific studies. In a recent age-related eye disease study from the U.S. National Eye Institute (AREDS2), 2 mg of zeaxanthin plus 10 mg of Kemin’s FloraGLO lutein was found to “slow the progression of age-related macular degeneration.”
ZeaONE is commercially available under the OptiSharp Natural brand from DSM (Parsippany, NJ).
Nutritional Outlook Magazine